Abstract
In a retrospective study comparing direct oral anticoagulants vs warfarin in this population, apixaban's adverse event rate was lower regardless of frailty status.
MeSH terms
-
Administration, Oral
-
Aged
-
Anticoagulants / adverse effects
-
Atrial Fibrillation* / complications
-
Atrial Fibrillation* / drug therapy
-
Frail Elderly
-
Humans
-
Retrospective Studies
-
Stroke* / drug therapy
-
Treatment Outcome